STOCK TITAN

Exponent Inc SEC Filings

EXPO NASDAQ

Welcome to our dedicated page for Exponent SEC filings (Ticker: EXPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Exponent Inc filings document operating results, Regulation FD disclosures, capital-return actions, and governance matters for a science and engineering consulting company. Recent Form 8-K reports record quarterly financial results, dividend declarations, and share repurchase authorizations tied to the company’s common stock.

Proxy materials cover shareholder voting matters, director elections, executive compensation, pay-versus-performance tables, and board governance. The filing record also includes material-event disclosures related to leadership and corporate governance, along with capital-structure disclosures relevant to Exponent’s public-company reporting.

Rhea-AI Summary

EXPO affiliate submitted a Form 144 notice to sell 4,194 shares of Common Stock via exercise of stock options on 05/15/2026. The filing also lists 10b5-1 sales by Catherine Corrigan in the prior three months: 3,909, 3,912, and 3,920 shares with gross proceeds reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Exponent Inc: Kayne Anderson Rudnick Investment Management, LLC reported beneficial ownership of 3,886,546 shares of Exponent Inc, representing 7.9% of the class as of 03/31/2026. The filing breaks down voting and dispositive power: sole voting power 2,839,655, shared voting power 1,042,670, sole dispositive power 2,843,876, and shared dispositive power 1,042,670.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Exponent Inc.’s Group Vice President Joseph Rakow reported an open-market sale of company stock. On May 13, 2026, he sold 2,945 shares of Exponent common stock at an average price of $54.6601 per share. Following this transaction, his directly held common stock position reported in this filing was 0 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Exponent Inc. Group Vice President Joseph Sala reported an open-market sale of Common Stock. On May 13, 2026, he sold 2,066 shares at $56.66 per share. Following this transaction, the filing shows Sala directly holding 0 shares of Exponent common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Morgan Stanley Smith Barney LLC filed a Form 144 reporting a proposed sale of Common Stock of EXPO with a filing date of 05/13/2026. The filing lists two blocks of restricted stock dated 03/11/2026 and 03/11/2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 relating to EXPO Common stock. The filing, dated 05/13/2026, lists proposed sales of Common shares identified as restricted stock including 986 shares issued 03/11/2026 and 1,080 shares issued 03/11/2022. The filing names NASDAQ as the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Exponent Inc Chief Financial Officer Eric R. Anderson filed an initial statement of beneficial ownership. He directly holds 2,955 shares of common stock. He also holds restricted stock units covering 4,750, 3,628, 3,538 and 3,000 shares of common stock on a 1-for-1 basis, plus options for 6,592 shares at an exercise price of $65.56 and 6,008 shares at $66.56 that become exercisable in four equal annual installments and expire in 2036.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Exponent, Inc. reported first-quarter 2026 revenue of $166.3 million, up 14.3% from $145.5 million a year earlier, driven by strong Engineering and Other Scientific work and AI-related user research and utility risk management projects. Revenues before reimbursements rose 10% to $151.8 million.

Net income increased 11% to $29.6 million, with diluted EPS rising to $0.59 from $0.52. EBITDA reached $43.1 million, and EBITDA as a percentage of revenues before reimbursements improved to 28.4%. The company returned capital through a $0.31 per-share dividend, Q1 share repurchases of about $78.8 million, and a new $50 million buyback authorization.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Exponent, Inc. reported solid first quarter 2026 results, with total revenues rising 14% to $166.3 million and revenues before reimbursements up 10% to $151.8 million versus the prior-year period. Net income increased to $29.6 million, or $0.59 per diluted share, compared to $26.7 million, or $0.52 per diluted share.

EBITDA grew to $43.1 million, representing a margin of 28.4% of net revenues, up from 27.3%. The company ended the quarter with $118.6 million in cash and cash equivalents after paying $16.6 million in dividends and repurchasing $78.8 million of stock.

The Board declared a regular quarterly dividend of $0.31 per share payable on June 18, 2026, to holders of record on June 5, 2026, and increased the stock repurchase authorization by $50 million, in addition to $17.7 million already available. Exponent expects high-single-digit growth in revenues before reimbursements and EBITDA margins in the high-20% range for the second quarter and full year 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.41%
Tags
current report
Rhea-AI Summary

Exponent, Inc. reported solid first quarter 2026 results, with total revenues rising 14% to $166.3 million and revenues before reimbursements up 10% to $151.8 million versus the prior-year period. Net income increased to $29.6 million, or $0.59 per diluted share, compared to $26.7 million, or $0.52 per diluted share.

EBITDA grew to $43.1 million, representing a margin of 28.4% of net revenues, up from 27.3%. The company ended the quarter with $118.6 million in cash and cash equivalents after paying $16.6 million in dividends and repurchasing $78.8 million of stock.

The Board declared a regular quarterly dividend of $0.31 per share payable on June 18, 2026, to holders of record on June 5, 2026, and increased the stock repurchase authorization by $50 million, in addition to $17.7 million already available. Exponent expects high-single-digit growth in revenues before reimbursements and EBITDA margins in the high-20% range for the second quarter and full year 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.41%
Tags
current report
-
Rhea-AI Summary

Exponent Inc Schedule 13G: Vanguard Capital Management reports beneficial ownership of 2,586,291 shares of Common Stock, representing 5.25% of the class as of 03/31/2026. The filing shows sole dispositive power over 2,586,291 shares and sole voting power for 375,641 shares. The disclosure states these holdings include securities held by Vanguard funds and managed accounts for which Vanguard Capital Management LLC and specified affiliates exercise dispositive or voting power.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership

FAQ

How many Exponent (EXPO) SEC filings are available on StockTitan?

StockTitan tracks 73 SEC filings for Exponent (EXPO), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Exponent (EXPO)?

The most recent SEC filing for Exponent (EXPO) was filed on May 15, 2026.